PATHOS: A phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV)-positive oropharyngeal cancer.

• Evans, Mererid Velindre NHS Trust, Cardiff, United Kingdom;
• Knott, Sarah Centre for Trials Research, Cardiff University, Cardiff, United Kingdom;
• Hurt, Chris Centre for Trials Research, Cardiff University, Cardiff, United Kingdom;
• Patterson, Joanne Newcastle University, Newcastle upon Tyne, United Kingdom;
• Robinson, Max Newcastle University, Newcastle-upon-Tyne, United Kingdom;
• Hutcheson, Kate A. The University of Texas MD Anderson Cancer Center, Houston, TX;
• Nixon, Lisette Cardiff University, Cardiff, United Kingdom;
• Beasley, Matthew Bristol Haematology and Oncology Centre, Bristol, United Kingdom;
• Lee, Jonny Mount Vernon Cancer Centre, London, United Kingdom;
• Wade, Wendy NISCHR CRC South East Wales Research Network, Cardiff, United Kingdom;
• Palaniappan, Nachi Velindre Cancer Centre, Cardiff, Wales;
• Simon, Christian CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;
• Powell, Ned HPV Oncology Group, Institute of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom;
• Greenhalf, William University of Liverpool, Liverpool, United Kingdom;
• Jones, Terry University of Liverpool, Liverpool, United Kingdom;

Cancer Research

Oncology